1. Home
  2. |Insights
  3. |DoD's New Year's Gift: More Time to Meet Cyber Safeguarding Requirements

DoD's New Year's Gift: More Time to Meet Cyber Safeguarding Requirements

Client Alert | less than 1 min read | 12.30.15

On December 30, DoD issued an interim rule amending the DFARS Safeguarding Rule in several respects, including to provide contractors up to December 31, 2017, to comply with the security control requirements identified in DFARS 252.204-7012, Safeguarding Covered Defense Information and Cyber Incident Reporting, and detailed in NIST Special Publication 800-171, Protecting Controlled Unclassified Information in Nonfederal Information Systems and Organizations. Despite the additional time to comply, within 30 days of contract award, contractors must still notify the DoD Chief Information Officer of any NIST SP 800-171 security requirements not yet implemented.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights